 Aparna Annam
Concepts (105)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiology | 3 | 2022 | 141 | 1.230 |
Why?
| | Radiologists | 2 | 2022 | 35 | 0.840 |
Why?
| | Patient Advocacy | 1 | 2022 | 66 | 0.770 |
Why?
| | Hepatic Veins | 1 | 2021 | 29 | 0.760 |
Why?
| | Portal Vein | 1 | 2021 | 76 | 0.730 |
Why?
| | Vascular Malformations | 1 | 2021 | 47 | 0.730 |
Why?
| | Professional Role | 1 | 2022 | 149 | 0.730 |
Why?
| | Wounds and Injuries | 2 | 2022 | 749 | 0.590 |
Why?
| | Spermatocele | 1 | 2015 | 2 | 0.490 |
Why?
| | Scrotum | 1 | 2015 | 23 | 0.480 |
Why?
| | Testis | 1 | 2015 | 133 | 0.470 |
Why?
| | International Educational Exchange | 1 | 2014 | 11 | 0.460 |
Why?
| | Testicular Neoplasms | 1 | 2015 | 96 | 0.440 |
Why?
| | Ultrasonography | 2 | 2022 | 634 | 0.420 |
Why?
| | Education, Medical, Graduate | 2 | 2023 | 368 | 0.390 |
Why?
| | Global Health | 1 | 2014 | 287 | 0.390 |
Why?
| | Pediatrics | 2 | 2021 | 980 | 0.370 |
Why?
| | Radiology, Interventional | 2 | 2021 | 26 | 0.360 |
Why?
| | Infant, Newborn | 6 | 2023 | 5047 | 0.240 |
Why?
| | Child | 11 | 2022 | 18415 | 0.230 |
Why?
| | Embolization, Therapeutic | 2 | 2022 | 178 | 0.210 |
Why?
| | Neonatology | 1 | 2022 | 17 | 0.210 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2023 | 101 | 0.200 |
Why?
| | Splenectomy | 1 | 2022 | 52 | 0.200 |
Why?
| | Noonan Syndrome | 1 | 2022 | 17 | 0.200 |
Why?
| | Hepatopulmonary Syndrome | 1 | 2021 | 24 | 0.190 |
Why?
| | Point-of-Care Systems | 1 | 2022 | 136 | 0.190 |
Why?
| | Quality Indicators, Health Care | 2 | 2021 | 287 | 0.190 |
Why?
| | Nephrostomy, Percutaneous | 1 | 2021 | 9 | 0.180 |
Why?
| | Expert Testimony | 1 | 2021 | 36 | 0.180 |
Why?
| | Urinary Catheterization | 1 | 2021 | 23 | 0.180 |
Why?
| | Cholecystostomy | 1 | 2020 | 4 | 0.180 |
Why?
| | Education, Medical | 1 | 2023 | 215 | 0.180 |
Why?
| | Urologic Diseases | 1 | 2021 | 35 | 0.180 |
Why?
| | Biliary Tract Surgical Procedures | 1 | 2020 | 21 | 0.180 |
Why?
| | Spleen | 1 | 2022 | 487 | 0.180 |
Why?
| | Radiography, Interventional | 1 | 2021 | 104 | 0.170 |
Why?
| | Empyema, Pleural | 1 | 2019 | 11 | 0.170 |
Why?
| | Chest Tubes | 1 | 2019 | 30 | 0.170 |
Why?
| | Humans | 19 | 2023 | 114689 | 0.160 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2021 | 241 | 0.160 |
Why?
| | Sclerotherapy | 1 | 2018 | 19 | 0.160 |
Why?
| | Hemangioma | 1 | 2019 | 41 | 0.160 |
Why?
| | Lymphatic Abnormalities | 1 | 2018 | 18 | 0.150 |
Why?
| | Doxycycline | 1 | 2018 | 55 | 0.150 |
Why?
| | Bronchitis | 1 | 2017 | 35 | 0.140 |
Why?
| | Fibrinolytic Agents | 1 | 2019 | 234 | 0.140 |
Why?
| | Secondary Prevention | 1 | 2018 | 222 | 0.140 |
Why?
| | Quality Improvement | 2 | 2021 | 950 | 0.130 |
Why?
| | Lung Diseases | 1 | 2022 | 701 | 0.120 |
Why?
| | Disease Management | 1 | 2019 | 560 | 0.120 |
Why?
| | Lymphography | 1 | 2014 | 6 | 0.120 |
Why?
| | Lymphatic Diseases | 1 | 2014 | 17 | 0.120 |
Why?
| | Liver Transplantation | 1 | 2021 | 707 | 0.120 |
Why?
| | Internship and Residency | 1 | 2023 | 926 | 0.120 |
Why?
| | Volunteers | 1 | 2014 | 31 | 0.110 |
Why?
| | Lymphatic Vessels | 1 | 2014 | 54 | 0.110 |
Why?
| | Child, Preschool | 5 | 2021 | 9116 | 0.110 |
Why?
| | Infant | 4 | 2021 | 7963 | 0.100 |
Why?
| | Skin Neoplasms | 1 | 2019 | 756 | 0.100 |
Why?
| | Antineoplastic Agents | 1 | 2022 | 1879 | 0.090 |
Why?
| | Practice Guidelines as Topic | 1 | 2019 | 1395 | 0.090 |
Why?
| | Postoperative Complications | 1 | 2021 | 2128 | 0.090 |
Why?
| | Diagnosis, Differential | 1 | 2015 | 1342 | 0.090 |
Why?
| | Lung | 1 | 2022 | 3561 | 0.080 |
Why?
| | Male | 6 | 2021 | 55599 | 0.080 |
Why?
| | Consensus | 2 | 2021 | 537 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 2 | 2018 | 3053 | 0.070 |
Why?
| | Adolescent | 4 | 2021 | 17848 | 0.070 |
Why?
| | Feasibility Studies | 2 | 2022 | 740 | 0.060 |
Why?
| | Neonatologists | 1 | 2022 | 3 | 0.050 |
Why?
| | Retrospective Studies | 4 | 2022 | 12551 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2022 | 113 | 0.050 |
Why?
| | Dyspnea | 1 | 2023 | 211 | 0.050 |
Why?
| | False Positive Reactions | 1 | 2022 | 109 | 0.050 |
Why?
| | Pyrimidinones | 1 | 2022 | 88 | 0.050 |
Why?
| | Pyridones | 1 | 2022 | 123 | 0.050 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2022 | 176 | 0.040 |
Why?
| | Thoracic Surgery, Video-Assisted | 1 | 2019 | 40 | 0.040 |
Why?
| | Thoracotomy | 1 | 2019 | 75 | 0.040 |
Why?
| | Trauma Centers | 1 | 2022 | 362 | 0.040 |
Why?
| | Drainage | 1 | 2019 | 151 | 0.040 |
Why?
| | Abdominal Cavity | 1 | 2018 | 5 | 0.040 |
Why?
| | Extravasation of Diagnostic and Therapeutic Materials | 1 | 2018 | 14 | 0.040 |
Why?
| | Thoracic Duct | 1 | 2017 | 3 | 0.040 |
Why?
| | Ultrasonography, Interventional | 1 | 2018 | 123 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2022 | 1693 | 0.040 |
Why?
| | Patient Safety | 1 | 2020 | 277 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2020 | 9088 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2019 | 1121 | 0.030 |
Why?
| | Recurrence | 1 | 2018 | 935 | 0.030 |
Why?
| | Length of Stay | 1 | 2019 | 962 | 0.030 |
Why?
| | Injections, Intralesional | 1 | 2014 | 32 | 0.030 |
Why?
| | Gadolinium DTPA | 1 | 2014 | 47 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1317 | 0.030 |
Why?
| | Altitude | 1 | 2017 | 432 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2022 | 2286 | 0.030 |
Why?
| | Contrast Media | 1 | 2014 | 345 | 0.020 |
Why?
| | Prospective Studies | 1 | 2022 | 6220 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2018 | 4411 | 0.020 |
Why?
| | Risk Factors | 1 | 2020 | 8632 | 0.020 |
Why?
| | Female | 3 | 2018 | 59511 | 0.020 |
Why?
| | United States | 1 | 2022 | 12183 | 0.020 |
Why?
| | Young Adult | 1 | 2014 | 10470 | 0.010 |
Why?
| | Adult | 1 | 2014 | 30550 | 0.010 |
Why?
|
|
Annam's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|